Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 379
5
Diseases
8
Unique genes
0.197
Avg. similarity score
Aicardi goutieres syndrome
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Aicardi goutieres syndrome
Interferonopathy
RNASEH2A-related type 1 interferonopathy
RNASEH2B-related type 1 interferonopathy
RNASEH2C-related type 1 interferonopathy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Aicardi goutieres syndrome | 4 | 4 | 8 |
| Interferonopathy | 4 | 4 | 4 |
| RNASEH2A-related type 1 interferonopathy | 2 | 2 | 1 |
| RNASEH2B-related type 1 interferonopathy | 2 | 2 | 1 |
| RNASEH2C-related type 1 interferonopathy | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| RNASEH2A | 3 / 5 | Aicardi goutieres syndrome, Interferonopathy, RNASEH2A-related type 1 interferonopathy |
| RNASEH2B | 3 / 5 | Aicardi goutieres syndrome, Interferonopathy, RNASEH2B-related type 1 interferonopathy |
| RNASEH2C | 3 / 5 | Aicardi goutieres syndrome, Interferonopathy, RNASEH2C-related type 1 interferonopathy |
| SAMHD1 | 2 / 5 | Aicardi goutieres syndrome, Interferonopathy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| DNA replication | KEGG | 3 / 36 | 125× | 1.37e-6 | 6.42e-5 ✓ sig. |
| Cytosolic DNA-sensing pathway | KEGG | 3 / 83 | 54.3× | 1.74e-5 | 5.33e-4 ✓ sig. |
| Regulation by TREX1 | Reactome | 1 / 1 | 1,501× | 6.66e-4 | 9.96e-3 ✓ sig. |
| Nucleobase catabolism | Reactome | 1 / 1 | 1,501× | 6.66e-4 | 9.96e-3 ✓ sig. |
| Interferon alpha/beta signaling | Reactome | 2 / 67 | 44.8× | 8.40e-4 | 1.19e-2 ✓ sig. |
| RIG-I-like receptor signaling pathway | KEGG | 2 / 72 | 41.7× | 9.70e-4 | 1.33e-2 ✓ sig. |
| C6 deamination of adenosine | Reactome | 1 / 2 | 751× | 1.33e-3 | 1.68e-2 ✓ sig. |
| Formation of editosomes by ADAR proteins | Reactome | 1 / 2 | 751× | 1.33e-3 | 1.68e-2 ✓ sig. |
| Measles | KEGG | 2 / 139 | 21.6× | 3.56e-3 | 3.47e-2 ✓ sig. |
| Influenza A | KEGG | 2 / 173 | 17.4× | 5.46e-3 | 4.64e-2 ✓ sig. |
| SLBP independent Processing of Histone Pre-mRNAs | Reactome | 1 / 10 | 150× | 6.64e-3 | 5.28e-2 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | Reactome | 1 / 11 | 136× | 7.31e-3 | 5.62e-2 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | Reactome | 1 / 12 | 125× | 7.97e-3 | 5.96e-2 |
| IRF3-mediated induction of type I IFN | Reactome | 1 / 13 | 115× | 8.63e-3 | 6.28e-2 |
| TRAF3-dependent IRF activation pathway | Reactome | 1 / 14 | 107× | 9.29e-3 | 6.56e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| mismatch repair | GO:0006298 | 4 / 30 | 311× | 3.76e-10 | 9.31e-8 ✓ sig. |
| negative regulation of type I interferon-mediated signaling pathway | GO:0060339 | 3 / 23 | 305× | 9.08e-8 | 1.11e-5 ✓ sig. |
| RNA catabolic process | GO:0006401 | 3 / 37 | 189× | 3.97e-7 | 3.85e-5 ✓ sig. |
| defense response to virus | GO:0051607 | 4 / 247 | 37.8× | 2.00e-6 | 1.44e-4 ✓ sig. |
| DNA replication | GO:0006260 | 3 / 131 | 53.5× | 1.84e-5 | 8.39e-4 ✓ sig. |
| innate immune response | GO:0045087 | 4 / 605 | 15.4× | 6.86e-5 | 2.28e-3 ✓ sig. |
| regulation of innate immune response | GO:0045088 | 2 / 32 | 146× | 7.90e-5 | 2.54e-3 ✓ sig. |
| type I interferon-mediated signaling pathway | GO:0060337 | 2 / 59 | 79.2× | 2.71e-4 | 6.25e-3 ✓ sig. |
| somatic diversification of immune receptors via somatic mutation | GO:0002566 | 1 / 1 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| negative regulation of post-transcriptional gene silencing by regulatory ncRNA | GO:1900369 | 1 / 1 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| ribonucleotide metabolic process | GO:0009259 | 1 / 1 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| immune response in brain or nervous system | GO:0002383 | 1 / 1 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| immune complex formation | GO:0097281 | 1 / 1 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| cellular response to virus | GO:0098586 | 2 / 89 | 52.5× | 6.16e-4 | 1.11e-2 ✓ sig. |
| regulation of type III interferon production | GO:0034344 | 1 / 2 | 1,168× | 8.56e-4 | 1.36e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Aicardi goutieres syndrome | Interferonopathy | 0.444 | 4 | 2.99e-14 | 4.26e-13 ✓ sig. |
| Interferonopathy | RNASEH2A-related type 1 interferonopathy | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Interferonopathy | RNASEH2B-related type 1 interferonopathy | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Interferonopathy | RNASEH2C-related type 1 interferonopathy | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Aicardi goutieres syndrome | RNASEH2A-related type 1 interferonopathy | 0.111 | 1 | 5.20e-4 | 1.04e-3 ✓ sig. |
| Aicardi goutieres syndrome | RNASEH2B-related type 1 interferonopathy | 0.111 | 1 | 5.20e-4 | 1.04e-3 ✓ sig. |
| Aicardi goutieres syndrome | RNASEH2C-related type 1 interferonopathy | 0.111 | 1 | 5.20e-4 | 1.04e-3 ✓ sig. |